Salesforce dipped around 8% today.
Might be due to the news that Britain has approved the use of vaccine, and it can be used to treat people next week.
I always use Tableau, and it is a important skill to me.
My work efficiency increased many times, and also people in the company values people with that skill.
I used to own Tableau shares, and when Salesforce bought over it, I sold it.
Because of the valuation.
But my mind set has changed regarding valuation, especially for disrupting companies.
I bought it at $222, and will buy again if it dips to $200.
At least I am buying a company that I am familiar with the product.
And I believe it can take over Microsoft Excel, in terms of market share.
Excel is still useful, but more people will find Tableau more useful. But I still need Excel in my current work.
And recently Salesforce released the news that they bought Slack.
Not very sure about that software, though I have heard of it.
And few months ago, they bought Zoom, which I use it at work too.
For this purchase, it is not close to any support line.
So I used moving average to understand entry points.
Current price is at 150 MA.
Next Entry price will be at 200 MA, which is $200.
No comments:
Post a Comment